Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 8, Issue 1, pp. 1
PubMed
Published By
Print ISSN
Online ISSN
History
- Published first January 2, 2020.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
January 2020
Volume 8, Issue 1
Volume 8, Issue 1
A Sampling of Highlights from the Literature
Jump to section
- Article
- Mitochondrial fragmentation limits NK cell–based tumor immunosurveillance
- Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
- Small-molecule MYC inhibitors suppress tumor growth and enhance immunotherapy
- Single-cell RNA sequencing reveals stromal evolution into LRRC15+ myofibroblasts as a determinant of patient response to cancer immunotherapy
- VISTA is an acidic pH-selective ligand for PSGL-1
- Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy
- Info & Metrics
Advertisement